IRIS
TURNATURI, RITA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.726
EU - Europa 2.601
AS - Asia 2.274
AF - Africa 430
SA - Sud America 364
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.402
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.599
SG - Singapore 1.088
IT - Italia 920
RU - Federazione Russa 783
CN - Cina 617
BR - Brasile 303
IE - Irlanda 233
CI - Costa d'Avorio 232
VN - Vietnam 168
DE - Germania 136
FR - Francia 123
UA - Ucraina 117
KR - Corea 108
CA - Canada 87
SN - Senegal 79
GB - Regno Unito 76
NG - Nigeria 50
IN - India 45
JP - Giappone 40
ES - Italia 37
HK - Hong Kong 37
BD - Bangladesh 32
FI - Finlandia 29
PL - Polonia 28
MX - Messico 25
IQ - Iraq 24
NL - Olanda 23
SE - Svezia 22
ZA - Sudafrica 22
AR - Argentina 20
ID - Indonesia 20
TR - Turchia 20
BE - Belgio 15
KE - Kenya 13
UZ - Uzbekistan 12
CZ - Repubblica Ceca 11
LT - Lituania 10
VE - Venezuela 10
AE - Emirati Arabi Uniti 9
BJ - Benin 9
EC - Ecuador 9
PK - Pakistan 9
AT - Austria 8
CL - Cile 7
EG - Egitto 7
LB - Libano 7
TN - Tunisia 7
AU - Australia 6
CO - Colombia 6
GR - Grecia 6
HU - Ungheria 6
SA - Arabia Saudita 6
JM - Giamaica 5
MA - Marocco 5
AZ - Azerbaigian 4
CR - Costa Rica 4
IL - Israele 4
PY - Paraguay 4
BG - Bulgaria 3
HR - Croazia 3
IR - Iran 3
OM - Oman 3
TH - Thailandia 3
AL - Albania 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
JO - Giordania 2
KZ - Kazakistan 2
LV - Lettonia 2
MY - Malesia 2
NP - Nepal 2
PH - Filippine 2
PS - Palestinian Territory 2
SV - El Salvador 2
UY - Uruguay 2
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
DK - Danimarca 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
KG - Kirghizistan 1
LY - Libia 1
NO - Norvegia 1
PE - Perù 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
TT - Trinidad e Tobago 1
Totale 10.402
Salva come PNG Salva come JPEG
Città #
Dallas 676
Singapore 644
Santa Clara 511
Houston 490
Chandler 451
San Jose 348
Moscow 339
Ashburn 273
Catania 250
Abidjan 232
Dublin 231
Chicago 225
Hefei 135
Beijing 115
Boardman 115
Seoul 108
Jacksonville 85
Los Angeles 82
Dakar 79
Civitanova Marche 70
Council Bluffs 70
Lauterbourg 70
Bremen 62
Andover 61
Cambridge 60
Lawrence 60
Nanjing 57
New York 46
Rome 42
Ho Chi Minh City 41
Buffalo 40
Toronto 37
Naples 36
The Dalles 35
Columbus 34
São Paulo 34
Des Moines 33
Hong Kong 33
Tokyo 31
Hanoi 30
Lagos 28
Wilmington 28
Munich 26
Messina 21
Montreal 21
Warsaw 21
Denver 20
Phoenix 20
London 18
San Giovanni la Punta 18
Brooklyn 17
Atlanta 16
Johannesburg 16
Orem 16
Shenyang 16
Abuja 15
Amsterdam 14
Brussels 14
Da Nang 14
Saint Petersburg 14
Changsha 13
Dong Ket 13
Jakarta 13
Frankfurt am Main 12
Jiaxing 12
Madrid 12
Milan 12
Paternò 12
Poplar 12
Salerno 12
Baghdad 11
San Mateo 11
Falls Church 10
Helsinki 10
Nanchang 10
Ottawa 10
Turku 10
Chennai 9
Cotonou 9
Haiphong 9
Lappeenranta 9
Mexico City 9
Pune 9
Rimini 9
Shanghai 9
Tianjin 9
Belo Horizonte 8
Bologna 8
Fortaleza 8
Grafing 8
Marseille 8
Paris 8
Pozzallo 8
Rio de Janeiro 8
Seattle 8
Tashkent 8
Washington 8
Brno 7
Cagliari 7
Jinan 7
Totale 7.129
Salva come PNG Salva come JPEG
Nome #
Simultaneous targeting of MOR/DOR: A useful strategy for inflammatory pain modulation 412
((2S)-N-2-methoxy-2-phenylethyl-6,7-benzomorphan compound (2S-LP2): Discovery of a biased mu/delta opioid receptor agonist 321
Neuroprotective effects of Rosmarinus officinalis L. extract in oxygen glucose deprivation (OGD)-injured human neural-like cells 203
Design, synthesis, in vitro evaluation, and molecular modeling studies of N-substituted benzomorphans, analogs of LP2, as novel MOR ligands 195
Benzomorphan skeleton, a versatile scaffold for different targets: A comprehensive review 186
(+)-and (−)-Phenazocine enantiomers: evaluation of their dual opioid agonist/σ1 antagonist properties and antinociceptive effects 185
A new Sigma-1 Receptor antagonist in Chronic Pain Treatment: (+)-2R/S-LP2 effects in inflammatory and neuropathic pain 171
Progress in the development of selective heme oxygenase-1 inhibitors and their potential therapeutic application 167
ANTIALLODINIC AND ANTIHYPERALGESIC EFFECTS OF LP1, AN OPIOID MULTITARGET LIGAND, IN INFLAMMATORY AND NEUROPATHIC PAIN STATES 162
A structure-and ligand-based virtual screening of a database of “small” marine natural products for the identification of “blue” sigma-2 receptor ligands 162
R- ed S-LP2: sintesi, molecular docking e valutazione farmacologica 159
Benzomorphan scaffold for opioid analgesics and pharmacological tools development: A comprehensive review 158
Haloperidol Metabolite II Valproate Ester (S)-(-)-MRJF22: Preliminary Studies as a Potential Multifunctional Agent Against Uveal Melanoma 157
Exploiting the Power of Stereochemistry in Drug Action: 3-[(2S,6S,11S)-8-Hydroxy-6,11-dimethyl-1,4,5,6-tetrahydro-2,6-methano-3-benzazocin-3(2H)-yl]-N-phenylpropanamide as Potent Sigma-1 Receptor Antagonist 154
Antinociceptive profile of LP1, a non-peptide multitarget opioid ligand. 153
Influenza del N-sostituente della (–)-cis-N-Normetazocina nella modulazione del profilo funzionale al MOR, DOR e KOR: da agonista ad antagonista attraverso ligandi misti agonisti/antagonisti 152
Intercellular communication and ion channels in neuropathic pain chronicization 151
Dual MOR/DOR agonist benzomorphan-based compounds for pain relief 148
CO2-derived non-isocyanate polyurethanes (NIPUs) and their potential applications 146
Sigma-1 Receptor Inhibition Reduces Mechanical Allodynia and Modulate Neuroinflammation in Chronic Neuropathic Pain 145
Design, synthesis and biological evaluation of novel aminopropylcarboxamide derivatives as sigma ligands 145
Development of novel LP1-based analogues with enhanced delta opioid receptor profile 144
The Multimodal MOPr/DOPr Agonist LP2 Reduces Allodynia in Chronic Constriction Injured Rats by Rescue of TGF-β1 Signalling 142
Antiproliferative and Antioxidant Activity of Glycoconjugates of Dithiocarbamates and Their Copper(II) and Zinc(II) Complexes 141
Novel N-Substituted Benzomorphan-Based Compounds: From MOR-Agonist/DOR-Antagonist to Biased/Unbiased MOR Agonists 141
Dual Sigma-1 receptor antagonists and hydrogen sulfide-releasing compounds for pain treatment: Design, synthesis, and pharmacological evaluation 140
Biotin-8-hydroxyquinoline conjugates and their metal complexes: Exploring the chemical properties and the antioxidant activity 139
Design and synthesis of trans-decahydroisoquinoline derivatives as new tramadol-like ligands 138
MOR/DOR targeting: an useful strategy in pain management 138
Dual-target ligands and pain: our experience 136
Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents 136
From plant to bench: natural products as source for analgesic drug development. 135
Synthesis, in vitro and in vivo characterization of new benzoxazole and benzothiazole-based sigma receptor ligands 133
Synthesis and Structure-Activity Relationships of LP1 Derivatives: N-Methyl-N-phenylethylamino Analogues as Novel MOR Agonists 132
LP2 e 2S-LP2: agonisti biased dual target MOR/DOR nel trattamento del dolore cronico 132
Simultaneous Activation of Mu and Delta Opioid Receptors Reduces Allodynia and Astrocytic Connexin 43 in an Animal Model of Neuropathic Pain 132
New selective Sigma-1/HDACi prodrugs for neurodegenerative disorders 131
Mu and Delta Opioid Receptor Targeting Reduces Connexin 43-Based Heterocellular Coupling during Neuropathic Pain 129
Design, synthesis, and biological evaluation of new hybrid MOR agonist/HDACi compounds: an innovative approach for persistent pain management 129
Correction to Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents 128
In Vitro Antioxidant Activity and In Vivo Topical Efficacy of Lipid Nanoparticles Co-Loading Idebenone and Tocopheryl Acetate 125
Novel N-normetazocine Derivatives with Opioid Agonist/Sigma-1 Receptor Antagonist Profile as Potential Analgesics in Inflammatory Pain 124
Multitarget Opioid/Non-opioid Ligands: A Potential Approach in Pain Management 121
Repeated activation of delta opiod receptors counteracts nerve injury-induced TNF-α up-regulation in the sciatic nerve of rats with neuropathic pain: A possible correlation with delta opiod receptors-mediated antiallodinic effect. 121
Targeting heme Oxygenase-1 with hybrid compounds to overcome Imatinib resistance in chronic myeloid leukemia cell lines 120
Analgesici oppioidi 119
Design, Synthesis and biological evaluation of hybrid MOR agonist/ HDACi molecules as potential therapeutic agents for chronic pain treatment 117
From Plant to Chemistry: Sources of Antinociceptive Non-Opioid Active Principles for Medicinal Chemistry and Drug Design 116
New Insights into the Opioid Analgesic Profile of cis-(-)-N-Normetazocine-derived Ligands 116
Design, synthesis and biological evaluation of MOR agonist/HDACi hybrid compounds: a new potential therapeutic strategy for persistent pain management 115
The benzomorphan-based LP1 ligand is a suitable MOR/DOR agonist for chronic pain treatment 115
THE BENZOMORPHAN-BASED COMPOUND LP1 AS A MULTITARGET OPIOID LIGAND FOR CHRONIC PAIN TREATMENT 115
Multitarget opioid ligands in pain relief: New players in an old game 111
The benzomorphan-based compound LP1 is a central acting MOR agonist/DOR antagonist suitable for chronic pain treatment 110
Progress in the development of more effective and safer analgesics for pain management 110
Evaluation of N-substituent structural variations in opioid receptor profile of LP1. 109
Tuning Properties for Blood-Brain Barrier Permeation: A Statistics-Based Analysis 109
Efficient green solvent-free CO2/epoxide cycloaddition catalyzed by a β-cyclodextrin-imidazolium-based ionic liquid 106
The Benzomorphan-Based Compound LP1 as Suitable Candidate for Pain Management 105
Hybrid MOR agonist/HDACi molecules as potential antinociceptive multi-target drugs: design, synthesis, and biological evaluation 104
Sigma Receptor Ligands Carrying a Nitric Oxide Donor Nitrate Moiety: Synthesis, In Silico, and Biological Evaluation 104
Rosemary Essential Oil-Loaded Lipid Nanoparticles: In Vivo Topical Activity from Gel Vehicles 102
The multitarget opioid ligand LP1's effects in persistent pain and in primary cell neuronal cultures 102
Differential scanning calorimetry approach to investigate the transfer of the multitarget opioid analgesic LP1 to biomembrane model 99
From agonist to antagonist profile in LP1 analogues through the introduction of different N-substituents in benzomorphan-based ligands 98
Synthesis and structure-activity relationships of (–)-cis-N-normetazocine-based LP1 derivatives 98
Idebenone: Novel strategies to improve its systemic and local efficacy 97
Novel N-normetazocine Derivatives with Opioid Agonist/Sigma-1 Receptor Antagonist Profile as Potential Analgesics for Pain Treatment 95
Tetrazine–trans-cyclooctene ligation: Unveiling the chemistry and applications within the human body 93
Simultaneous activation of mu and delta opioid receptors reduces allodynia and astrocytic connexin 43 in an animal model of neuropathic pain 93
Modulation of opioid receptor profile of LP1 analogues through the introduction of different N-substituents 89
Hybrid MOR agonist/HDACi molecules as potential new drugs for persistant pain management: design, synthesis and biological evaluation 88
Resveratrol-loaded lipid nanocarriers: Correlation between in vitro occlusion factor and in vivo skin hydrating effect 88
Solid lipid nanoparticles as carriers for the synthetic opioid lp2: Characterization and in vitro release 86
Multitarget MOR/DOR antinociceptive ligands as useful profile in pain management: synthesis and pharmacological studies of 6,7-benzomorphan-based LP2 and its isomers 86
MOR/DOR Dual-Target Approach: 2S-LP2 Effects in Inflammatory and Neuropathic Pain 86
IDEBENONE LOADED LIPID NANOPARTICLES: EVALUATION OF IN VITRO ANTIOXIDANT ACTIVITY AND IN VIVO TOPICAL EFFECTS 81
In Vitro Evaluation of Sunscreen Safety: Effects of the Vehicle and Repeated Applications on Skin Permeation from Topical Formulations 77
NEW PLAYERS IN AN OLD GAME: Pharmacological Evaluation of the Benzomorphan-Based Compound LP1. Design and Synthesis of Conformationally Constrained Compounds as New Tramadol-like Candidates. 76
THE BENZOMORPHAN-BASED LP1 IS A CENTRAL-ACTING MULTITARGET OPIOID LIGAND FOR CHRONIC PAIN TREATMENT 74
Synthesis and structure-activity relationships of (-)-cis-N-Normetazocine-based LP1 derivatives 70
NEW BENZOMORPHAN-BASED LP1 LIGAND AS SUITABLE MIXED MOP/DOP RECEPTORS AGONIST FOR CHRONIC PAIN TREATMENT 63
Discovery of a novel series of potent carbonic anhydrase inhibitors with selective affinity for μ Opioid receptor for Safer and long-lasting analgesia 30
Totale 10.671
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.679
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.679
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202131 0 0 0 0 0 0 0 0 0 0 0 31
2021/2022544 43 58 10 17 82 10 73 24 41 24 20 142
2022/20231.239 90 79 32 192 96 165 7 244 220 30 52 32
2023/2024721 33 102 43 32 53 193 35 55 2 23 106 44
2024/20252.298 53 340 113 188 442 307 187 97 125 143 150 153
2025/20264.508 313 225 817 271 645 921 449 98 259 285 136 89
Totale 10.671